SIM
SUPN icon

Sonora Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Sonora Investment Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,838
Closed -$44K – 1881
2020
Q2 		$44K Hold
1,838
– – ﹤0.01% 556
2020
Q1 		$33K Hold
1,838
– – ﹤0.01% 592
2019
Q4 		$44K Hold
1,838
– – ﹤0.01% 597
2019
Q3 		$51K Buy
+1,838
New +$54.5K 0.01% 517
2016
Q3 		– Sell
-35
Closed -$713 – 882
2016
Q2 		$713 Hold
35
– – ﹤0.01% 814
2016
Q1 		$614 Hold
35
– – ﹤0.01% 907
2015
Q4 		$0 Hold
35
– – ﹤0.01% 1121
2015
Q3 		$1K Buy
+35
New +$651 ﹤0.01% 1064

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Sonora Investment Management's SUPN Position: Q3 2020 in Review

Sonora Investment Management sold out of Supernus Pharmaceuticals (SUPN) in Q3 2020, closing a stake of 1,838 shares — an estimated $44K sold.

Sonora Investment Management first reported a position in SUPN in Q3 2015 and held it in 8 quarters. The position peaked at $51K in Q3 2019. 209 funds tracked by Wall St. Rank hold SUPN as of Q3 2020.

  • Sonora Investment Management reported no remaining Supernus Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Sonora Investment Management sold 1,838 Supernus Pharmaceuticals shares in Q3 2020, an estimated $44K.
  • Sonora Investment Management first reported a position in Supernus Pharmaceuticals in Q3 2015 and held it in 8 quarters.
  • Sonora Investment Management's Supernus Pharmaceuticals position peaked at $51K in Q3 2019.
  • 209 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2020.

Based on Sonora Investment Management's 13F filing for Q3 2020, filed 26 Oct 2020.